Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling

  • Govindasamy-Muralidharan Karthik1,
  • Mattias Rantalainen2,
  • Gustav Stålhammar1, 3,
  • John Lövrot1,
  • Ikram Ullah1,
  • Amjad Alkodsi4,
  • Ran Ma1,
  • Lena Wedlund5,
  • Johan Lindberg2,
  • Jan Frisell6,
  • Jonas Bergh1, 7 and
  • Johan Hartman1, 5, 8Email authorView ORCID ID profile
Contributed equally
BMC Cancer201717:802

https://doi.org/10.1186/s12885-017-3815-2

Received: 12 September 2017

Accepted: 21 November 2017

Published: 29 November 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
12 Sep 2017 Submitted Original manuscript
15 Sep 2017 Author responded Author comments - Karthik Govindasamy Muralidharan
15 Oct 2017 Reviewed Reviewer Report - Amarpreet Bhalla
23 Oct 2017 Reviewed Reviewer Report - Josip Blonder
Resubmission - Version 2
15 Sep 2017 Submitted Manuscript version 2
15 Oct 2017 Reviewed Reviewer Report - Amarpreet Bhalla
23 Oct 2017 Reviewed Reviewer Report - Josip Blonder
3 Nov 2017 Author responded Author comments - Karthik Govindasamy Muralidharan
Resubmission - Version 3
3 Nov 2017 Submitted Manuscript version 3
16 Nov 2017 Author responded Author comments - Karthik Govindasamy Muralidharan
Resubmission - Version 4
16 Nov 2017 Submitted Manuscript version 4
Publishing
21 Nov 2017 Editorially accepted
29 Nov 2017 Article published 10.1186/s12885-017-3815-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Oncology and Pathology, Karolinska Institutet, CCK
(2)
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
(3)
St. Erik Eye Hospital
(4)
Genome-Scale Biology Research Program Unit, Faculty of Medicine, University of Helsinki
(5)
Department of Clinical Pathology and Cytology, Karolinska University Laboratory
(6)
Department of Molecular Medicine and Surgery, Karolinska University Hospital
(7)
Radiumhemmet – Karolinska Oncology, Karolinska University Hospital
(8)
Department of Clinical Science and Education, Karolinska Institutet

Advertisement